Ruxolitinib Best Option When Glucocorticoids Fail Against Chronic GVHD Ruxolitinib Best Option When Glucocorticoids Fail Against Chronic GVHD

When chronic graft-versus-host disease follows an allogeneic stem-cell transplant, and it ' s either resistant to standard glucocorticoid therapy or dependent on glucocorticoids, according to the REACH3 trial.Reuters Health Information
Source: Medscape Transplantation Headlines - Category: Transplant Surgery Tags: Allergy & Clinical Immunology News Source Type: news